Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.

@article{Damaskos2017HistoneDI,
  title={Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.},
  author={Christos Damaskos and Nikolaos Garmpis and Serena I Valsami and Michael Kontos and Eleftherios Spartalis and Theodoros Kalampokas and Emmanouil E Kalampokas and Antonios K Athanasiou and Dimitrios Moris and Afrodite Daskalopoulou and Spyridon Davakis and Gerasimos S. Tsourouflis and Konstantinos C Kontzoglou and Despina N. Perrea and Nikolaos I Nikiteas and Dimitrios Dimitroulis},
  journal={Anticancer research},
  year={2017},
  volume={37 1},
  pages={35-46}
}
With a lifetime risk estimated to be one in eight in industrialized countries, breast cancer is the most frequent type of cancer among women worldwide. Patients are often treated with anti-estrogens, but it is common that some tumors develop resistance to therapy. The causation and progression of cancer is controlled by epigenetic processes, so there is an ongoing interest in research into mechanisms, genes and signaling pathways associating carcinogenesis with epigenetic modulation of gene… CONTINUE READING